Trophectoderm-specific gene manipulation using adeno-associated viral vectors

In mammals, blastocyst-stage trophectoderm (TE) contacts the maternal body at the time of implantation and forms the placenta after implantation, which supports the development of the fetus. Studying gene function in TE and placenta is important to understand normal implantation and pregnancy processes and their dysfunction. However, genetically modified mice are commonly generated by manipulating pronuclear-stage zygotes, which modify both the genome of the fetus and the placenta. Therefore, we previously developed TE/placenta-specific gene expression technology by transducing blastocysts with lentiviral vectors. However, the zona pellucida (ZP) needed to be removed before transduction. In this study, we examined various adeno-associated viral (AAV) vectors to develop a new TE/placenta-specific gene transduction method. As AAV1 can path through ZP, we succeeded in trophoblast-specific gene expression without ZP removal. Furthermore, TE cells genetically modified by AAV1-Cre contributed uniformly to the placenta. Our new technology contributes to advances in implantation and placenta research and leads to the development of new assisted reproductive technology.

Authors

Institutions

Publication Details

Journal
EXPERIMENTAL ANIMALS
Published
2025-01-01
DOI
https://doi.org/10.1538/expanim.24-0165
Citations
4
Primary Topic
Virus-based gene therapy research
Type
article
Field-Weighted Citation Impact
7.27

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Trophectoderm-specific gene manipulation using adeno-associated viral vectors

Chihiro Emori, Masahito Ikawa, Tatsuya Nakagawa
4 citations
EXPERIMENTAL ANIMALS
Virus-based gene therapy research
7.27
article

Trophectoderm-specific gene manipulation using adeno-associated viral vectors

Chihiro Emori, Masahito Ikawa, Tatsuya Nakagawa
article en
4 citations

Abstract

In mammals, blastocyst-stage trophectoderm (TE) contacts the maternal body at the time of implantation and forms the placenta after implantation, which supports the development of the fetus. Studying gene function in TE and placenta is important to understand normal implantation and pregnancy processes and their dysfunction. However, genetically modified mice are commonly generated by manipulating pronuclear-stage zygotes, which modify both the genome of the fetus and the placenta. Therefore, we previously developed TE/placenta-specific gene expression technology by transducing blastocysts with lentiviral vectors. However, the zona pellucida (ZP) needed to be removed before transduction. In this study, we examined various adeno-associated viral (AAV) vectors to develop a new TE/placenta-specific gene transduction method. As AAV1 can path through ZP, we succeeded in trophoblast-specific gene expression without ZP removal. Furthermore, TE cells genetically modified by AAV1-Cre contributed uniformly to the placenta. Our new technology contributes to advances in implantation and placenta research and leads to the development of new assisted reproductive technology.

EXPERIMENTAL ANIMALSVol. 74(3)
The University of Tokyo (JP), The University of Osaka (JP)
Japan Agency for Medical Research and Development, Japan Society for the Promotion of Science, Japan Science and Technology Agency
Zero hunger
Openalex Percentile: Top 4%
Virus-based gene therapy research
7.27
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.